NeuroOne Medical Technologies Co. (NASDAQ:NMTC - Get Free Report) CEO David A. Rosa bought 100,000 shares of the firm's stock in a transaction dated Friday, April 4th. The shares were purchased at an average price of $0.50 per share, with a total value of $50,000.00. Following the acquisition, the chief executive officer now directly owns 1,161,289 shares in the company, valued at approximately $580,644.50. This trade represents a 9.42 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
NeuroOne Medical Technologies Stock Up 2.3 %
Shares of NMTC stock opened at $0.44 on Wednesday. NeuroOne Medical Technologies Co. has a fifty-two week low of $0.41 and a fifty-two week high of $1.39. The firm's 50 day moving average price is $0.99 and its two-hundred day moving average price is $0.93. The stock has a market cap of $13.58 million, a price-to-earnings ratio of -1.69 and a beta of 0.61.
NeuroOne Medical Technologies (NASDAQ:NMTC - Get Free Report) last posted its earnings results on Wednesday, February 12th. The company reported $0.06 earnings per share for the quarter. NeuroOne Medical Technologies had a negative net margin of 82.17% and a negative return on equity of 270.70%.
Hedge Funds Weigh In On NeuroOne Medical Technologies
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Jane Street Group LLC purchased a new stake in shares of NeuroOne Medical Technologies during the fourth quarter valued at approximately $33,000. Geode Capital Management LLC grew its holdings in NeuroOne Medical Technologies by 9.8% during the 4th quarter. Geode Capital Management LLC now owns 311,659 shares of the company's stock valued at $257,000 after purchasing an additional 27,804 shares in the last quarter. Finally, XTX Topco Ltd purchased a new stake in NeuroOne Medical Technologies during the 3rd quarter worth $26,000. 16.07% of the stock is owned by institutional investors and hedge funds.
NeuroOne Medical Technologies Company Profile
(
Get Free Report)
NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
